Ross Lieb

Ross Lieb serves as the Chief Financial Officer at MedSpeed since October 2025. Previously, Ross held significant roles at Antylia Scientific, including Vice President of Finance and Head of M&A, where notable achievements included leading the $1.34 billion sale of the company to Brookfield Asset Management and overseeing five acquisitions that generated over $100 million in revenue. Ross's earlier experience includes various finance roles at EVRAZ North America, where responsibilities spanned strategic initiatives and financial planning, and a tenure at Deloitte focusing on corporate restructuring and performance improvement. Ross holds an MBA from The University of Chicago Booth School of Business and a Bachelor of Science in Finance, Accounting, and Marketing from Syracuse University.